Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin

30 Nov 2016

Abstract excerpt

// Cynthia Licona 1, * , Marie-Elodie Spaety 1, * , Antonelle Capuozzo 1, 6 , Moussa Ali 4 , Rita Santamaria 6 , Olivier Armant 2 , Francois Delalande 5 , Alain Van Dorsselaer 5 , Sarah Cianferani 5 , John Spencer 3 , Michel Pfeffer 4 , Georg Mellitzer 1 , Christian Gaiddon 1 1 INSERM 1113, Molecular Signaling of the Cell Stress Response and Pathology, Université de Strasbourg, Section Oncologie FMTS, Strasbourg,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Histone Deacetylase Inhibitors Research
Share to Metal complexes synthesis and properties

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27935863
DOI: 10.18632/oncotarget.13711

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatinPMID 27935863Read ↗

Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer TherapeuticsSemantic proximity Read ↗

Novel epigenetic therapeutic strategies and targets in cancerSemantic proximity Read ↗

Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer TherapySemantic proximity Read ↗

The role of oxidative stress in activity of anticancer thiosemicarbazonesSemantic proximity Read ↗

Metal-based anticancer drugs: From a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biologySemantic proximity Read ↗

Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and IsothiocyanatesSemantic proximity Read ↗

Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatinSemantic proximity Read ↗

Third row transition metals for the treatment of cancerSemantic proximity Read ↗

Remodeling the Epigenetic Landscape of Cancer—Application Potential of Flavonoids in the Prevention and Treatment of CancerSemantic proximity Read ↗

The Roles of Histone Modifications in Metal-Induced Neurological DisordersSemantic proximity Read ↗

Platinum Complexes as Anticancer AgentsSemantic proximity Read ↗

Metal-based antitumour drugs in the post genomic eraSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.